nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—CYP2C19—prostate cancer	0.235	1	CbGaD
Desloratadine—CYP2C19—Nilutamide—prostate cancer	0.0372	0.0727	CbGbCtD
Desloratadine—CYP2C19—Bicalutamide—prostate cancer	0.0372	0.0727	CbGbCtD
Desloratadine—CYP2C9—Nilutamide—prostate cancer	0.0309	0.0604	CbGbCtD
Desloratadine—CYP2C9—Bicalutamide—prostate cancer	0.0309	0.0604	CbGbCtD
Desloratadine—CYP2C19—Flutamide—prostate cancer	0.0308	0.0602	CbGbCtD
Desloratadine—CYP1A2—Flutamide—prostate cancer	0.0284	0.0556	CbGbCtD
Desloratadine—CYP2D6—Bicalutamide—prostate cancer	0.0282	0.0553	CbGbCtD
Desloratadine—ABCB1—Estramustine—prostate cancer	0.0279	0.0545	CbGbCtD
Desloratadine—CYP2D6—Abiraterone—prostate cancer	0.0234	0.0458	CbGbCtD
Desloratadine—CYP1A2—Estrone—prostate cancer	0.0205	0.0402	CbGbCtD
Desloratadine—CYP2C9—Estrone—prostate cancer	0.0185	0.0362	CbGbCtD
Desloratadine—ABCB1—Cabazitaxel—prostate cancer	0.0184	0.0359	CbGbCtD
Desloratadine—ABCB1—Estrone—prostate cancer	0.018	0.0351	CbGbCtD
Desloratadine—ABCB1—Ethinyl Estradiol—prostate cancer	0.016	0.0313	CbGbCtD
Desloratadine—CYP2C9—Capecitabine—prostate cancer	0.014	0.0274	CbGbCtD
Desloratadine—CYP1A2—Conjugated Estrogens—prostate cancer	0.0134	0.0263	CbGbCtD
Desloratadine—CYP2C19—Estradiol—prostate cancer	0.0128	0.025	CbGbCtD
Desloratadine—CYP1A2—Estradiol—prostate cancer	0.0118	0.0231	CbGbCtD
Desloratadine—ABCB1—Conjugated Estrogens—prostate cancer	0.0117	0.023	CbGbCtD
Desloratadine—CYP2C19—Prednisone—prostate cancer	0.011	0.0215	CbGbCtD
Desloratadine—ABCB1—Mitoxantrone—prostate cancer	0.0107	0.0209	CbGbCtD
Desloratadine—CYP2C9—Estradiol—prostate cancer	0.0106	0.0208	CbGbCtD
Desloratadine—ABCB1—Estradiol—prostate cancer	0.0103	0.0202	CbGbCtD
Desloratadine—ABCB1—Prednisone—prostate cancer	0.00887	0.0174	CbGbCtD
Desloratadine—CYP1A2—Etoposide—prostate cancer	0.0077	0.0151	CbGbCtD
Desloratadine—ABCB1—Etoposide—prostate cancer	0.00674	0.0132	CbGbCtD
Desloratadine—ABCB1—Docetaxel—prostate cancer	0.00616	0.0121	CbGbCtD
Desloratadine—ABCB1—Doxorubicin—prostate cancer	0.00459	0.00899	CbGbCtD
Desloratadine—CYP2D6—Doxorubicin—prostate cancer	0.00433	0.00847	CbGbCtD
Desloratadine—CYP2C19—urine—prostate cancer	0.00195	0.19	CbGeAlD
Desloratadine—CYP1A2—urine—prostate cancer	0.00159	0.155	CbGeAlD
Desloratadine—CYP2C9—urine—prostate cancer	0.00151	0.147	CbGeAlD
Desloratadine—CYP2D6—urine—prostate cancer	0.00113	0.111	CbGeAlD
Desloratadine—Loratadine—CYP2C19—prostate cancer	0.000557	0.434	CrCbGaD
Desloratadine—HRH1—prostate gland—prostate cancer	0.000535	0.0522	CbGeAlD
Desloratadine—HRH1—epithelium—prostate cancer	0.000393	0.0384	CbGeAlD
Desloratadine—CYP1A2—renal system—prostate cancer	0.00039	0.038	CbGeAlD
Desloratadine—Azatadine—CYP3A4—prostate cancer	0.000374	0.291	CrCbGaD
Desloratadine—HRH1—urethra—prostate cancer	0.000358	0.035	CbGeAlD
Desloratadine—Loratadine—CYP3A4—prostate cancer	0.000354	0.276	CrCbGaD
Desloratadine—ABCB1—prostate gland—prostate cancer	0.000293	0.0286	CbGeAlD
Desloratadine—CYP2D6—renal system—prostate cancer	0.000277	0.0271	CbGeAlD
Desloratadine—ABCB1—seminal vesicle—prostate cancer	0.000248	0.0242	CbGeAlD
Desloratadine—HRH1—testis—prostate cancer	0.000236	0.023	CbGeAlD
Desloratadine—ABCB1—epithelium—prostate cancer	0.000215	0.021	CbGeAlD
Desloratadine—ABCB1—renal system—prostate cancer	0.0002	0.0195	CbGeAlD
Desloratadine—ABCB1—urethra—prostate cancer	0.000196	0.0191	CbGeAlD
Desloratadine—CYP2D6—testis—prostate cancer	0.000179	0.0175	CbGeAlD
Desloratadine—HRH1—lymph node—prostate cancer	0.000171	0.0167	CbGeAlD
Desloratadine—ABCB1—bone marrow—prostate cancer	0.000151	0.0147	CbGeAlD
Desloratadine—ABCB1—testis—prostate cancer	0.000129	0.0126	CbGeAlD
Desloratadine—Mental disorder—Docetaxel—prostate cancer	0.000116	0.000782	CcSEcCtD
Desloratadine—Body temperature increased—Estradiol—prostate cancer	0.000116	0.000779	CcSEcCtD
Desloratadine—Abdominal pain—Estradiol—prostate cancer	0.000116	0.000779	CcSEcCtD
Desloratadine—Nasopharyngitis—Epirubicin—prostate cancer	0.000116	0.000779	CcSEcCtD
Desloratadine—Headache—Goserelin—prostate cancer	0.000116	0.000778	CcSEcCtD
Desloratadine—Erythema—Docetaxel—prostate cancer	0.000115	0.000777	CcSEcCtD
Desloratadine—Rash—Conjugated Estrogens—prostate cancer	0.000115	0.000776	CcSEcCtD
Desloratadine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000115	0.000775	CcSEcCtD
Desloratadine—Headache—Conjugated Estrogens—prostate cancer	0.000114	0.000771	CcSEcCtD
Desloratadine—Hallucination—Prednisone—prostate cancer	0.000114	0.000766	CcSEcCtD
Desloratadine—Anaphylactic shock—Etoposide—prostate cancer	0.000113	0.000763	CcSEcCtD
Desloratadine—Mood swings—Doxorubicin—prostate cancer	0.000113	0.000763	CcSEcCtD
Desloratadine—Infection—Etoposide—prostate cancer	0.000113	0.000758	CcSEcCtD
Desloratadine—Mental disorder—Capecitabine—prostate cancer	0.000112	0.000757	CcSEcCtD
Desloratadine—Connective tissue disorder—Prednisone—prostate cancer	0.000112	0.000757	CcSEcCtD
Desloratadine—Erythema—Capecitabine—prostate cancer	0.000112	0.000753	CcSEcCtD
Desloratadine—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000111	0.00075	CcSEcCtD
Desloratadine—Tachycardia—Etoposide—prostate cancer	0.000111	0.000745	CcSEcCtD
Desloratadine—Nausea—Goserelin—prostate cancer	0.00011	0.000738	CcSEcCtD
Desloratadine—Nausea—Conjugated Estrogens—prostate cancer	0.000109	0.000731	CcSEcCtD
Desloratadine—Urticaria—Mitoxantrone—prostate cancer	0.000108	0.000729	CcSEcCtD
Desloratadine—Breast disorder—Doxorubicin—prostate cancer	0.000108	0.000728	CcSEcCtD
Desloratadine—Anorexia—Etoposide—prostate cancer	0.000108	0.000728	CcSEcCtD
Desloratadine—Hypersensitivity—Estradiol—prostate cancer	0.000108	0.000726	CcSEcCtD
Desloratadine—Body temperature increased—Mitoxantrone—prostate cancer	0.000108	0.000726	CcSEcCtD
Desloratadine—Abdominal pain—Mitoxantrone—prostate cancer	0.000108	0.000726	CcSEcCtD
Desloratadine—Bronchitis—Epirubicin—prostate cancer	0.000107	0.000724	CcSEcCtD
Desloratadine—Nasopharyngitis—Doxorubicin—prostate cancer	0.000107	0.00072	CcSEcCtD
Desloratadine—Asthenia—Estradiol—prostate cancer	0.000105	0.000707	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000104	0.000699	CcSEcCtD
Desloratadine—Pruritus—Estradiol—prostate cancer	0.000103	0.000697	CcSEcCtD
Desloratadine—Palpitations—Docetaxel—prostate cancer	0.000102	0.000687	CcSEcCtD
Desloratadine—Dyspnoea—Etoposide—prostate cancer	0.000101	0.000681	CcSEcCtD
Desloratadine—Somnolence—Etoposide—prostate cancer	0.000101	0.000679	CcSEcCtD
Desloratadine—Cough—Docetaxel—prostate cancer	0.000101	0.000678	CcSEcCtD
Desloratadine—Hypersensitivity—Mitoxantrone—prostate cancer	0.0001	0.000676	CcSEcCtD
Desloratadine—Mental disorder—Prednisone—prostate cancer	0.0001	0.000675	CcSEcCtD
Desloratadine—Diarrhoea—Estradiol—prostate cancer	0.0001	0.000674	CcSEcCtD
Desloratadine—Convulsion—Docetaxel—prostate cancer	0.0001	0.000674	CcSEcCtD
Desloratadine—Infestation—Epirubicin—prostate cancer	9.96e-05	0.000671	CcSEcCtD
Desloratadine—Infestation NOS—Epirubicin—prostate cancer	9.96e-05	0.000671	CcSEcCtD
Desloratadine—Erythema—Prednisone—prostate cancer	9.95e-05	0.00067	CcSEcCtD
Desloratadine—Bronchitis—Doxorubicin—prostate cancer	9.94e-05	0.00067	CcSEcCtD
Desloratadine—Palpitations—Capecitabine—prostate cancer	9.87e-05	0.000665	CcSEcCtD
Desloratadine—Decreased appetite—Etoposide—prostate cancer	9.85e-05	0.000664	CcSEcCtD
Desloratadine—Myalgia—Docetaxel—prostate cancer	9.82e-05	0.000662	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Etoposide—prostate cancer	9.78e-05	0.000659	CcSEcCtD
Desloratadine—Asthenia—Mitoxantrone—prostate cancer	9.78e-05	0.000658	CcSEcCtD
Desloratadine—Fatigue—Etoposide—prostate cancer	9.77e-05	0.000658	CcSEcCtD
Desloratadine—Cough—Capecitabine—prostate cancer	9.75e-05	0.000657	CcSEcCtD
Desloratadine—Urinary tract infection—Epirubicin—prostate cancer	9.68e-05	0.000652	CcSEcCtD
Desloratadine—Dizziness—Estradiol—prostate cancer	9.67e-05	0.000651	CcSEcCtD
Desloratadine—Dry mouth—Docetaxel—prostate cancer	9.61e-05	0.000647	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Doxorubicin—prostate cancer	9.61e-05	0.000647	CcSEcCtD
Desloratadine—Myalgia—Capecitabine—prostate cancer	9.51e-05	0.000641	CcSEcCtD
Desloratadine—Hepatobiliary disease—Epirubicin—prostate cancer	9.42e-05	0.000635	CcSEcCtD
Desloratadine—Anaphylactic shock—Docetaxel—prostate cancer	9.42e-05	0.000634	CcSEcCtD
Desloratadine—Oedema—Docetaxel—prostate cancer	9.42e-05	0.000634	CcSEcCtD
Desloratadine—Epistaxis—Epirubicin—prostate cancer	9.39e-05	0.000633	CcSEcCtD
Desloratadine—Infection—Docetaxel—prostate cancer	9.36e-05	0.00063	CcSEcCtD
Desloratadine—ABCB1—lymph node—prostate cancer	9.35e-05	0.00912	CbGeAlD
Desloratadine—Diarrhoea—Mitoxantrone—prostate cancer	9.32e-05	0.000628	CcSEcCtD
Desloratadine—Dry mouth—Capecitabine—prostate cancer	9.3e-05	0.000627	CcSEcCtD
Desloratadine—Vomiting—Estradiol—prostate cancer	9.3e-05	0.000626	CcSEcCtD
Desloratadine—Gastrointestinal pain—Etoposide—prostate cancer	9.27e-05	0.000624	CcSEcCtD
Desloratadine—Nervous system disorder—Docetaxel—prostate cancer	9.24e-05	0.000622	CcSEcCtD
Desloratadine—Rash—Estradiol—prostate cancer	9.22e-05	0.000621	CcSEcCtD
Desloratadine—Infestation NOS—Doxorubicin—prostate cancer	9.22e-05	0.000621	CcSEcCtD
Desloratadine—Infestation—Doxorubicin—prostate cancer	9.22e-05	0.000621	CcSEcCtD
Desloratadine—Dermatitis—Estradiol—prostate cancer	9.21e-05	0.00062	CcSEcCtD
Desloratadine—Tachycardia—Docetaxel—prostate cancer	9.19e-05	0.000619	CcSEcCtD
Desloratadine—Headache—Estradiol—prostate cancer	9.16e-05	0.000617	CcSEcCtD
Desloratadine—Agitation—Prednisone—prostate cancer	9.15e-05	0.000616	CcSEcCtD
Desloratadine—Oedema—Capecitabine—prostate cancer	9.12e-05	0.000614	CcSEcCtD
Desloratadine—Angioedema—Prednisone—prostate cancer	9.09e-05	0.000613	CcSEcCtD
Desloratadine—Infection—Capecitabine—prostate cancer	9.06e-05	0.00061	CcSEcCtD
Desloratadine—Urticaria—Etoposide—prostate cancer	9e-05	0.000606	CcSEcCtD
Desloratadine—Anorexia—Docetaxel—prostate cancer	8.98e-05	0.000605	CcSEcCtD
Desloratadine—Abdominal pain—Etoposide—prostate cancer	8.96e-05	0.000603	CcSEcCtD
Desloratadine—Body temperature increased—Etoposide—prostate cancer	8.96e-05	0.000603	CcSEcCtD
Desloratadine—Urinary tract infection—Doxorubicin—prostate cancer	8.96e-05	0.000603	CcSEcCtD
Desloratadine—Nervous system disorder—Capecitabine—prostate cancer	8.94e-05	0.000602	CcSEcCtD
Desloratadine—Hepatitis—Epirubicin—prostate cancer	8.94e-05	0.000602	CcSEcCtD
Desloratadine—Tachycardia—Capecitabine—prostate cancer	8.9e-05	0.000599	CcSEcCtD
Desloratadine—Pharyngitis—Epirubicin—prostate cancer	8.87e-05	0.000598	CcSEcCtD
Desloratadine—Connective tissue disorder—Epirubicin—prostate cancer	8.79e-05	0.000592	CcSEcCtD
Desloratadine—Hepatobiliary disease—Doxorubicin—prostate cancer	8.72e-05	0.000587	CcSEcCtD
Desloratadine—Epistaxis—Doxorubicin—prostate cancer	8.69e-05	0.000586	CcSEcCtD
Desloratadine—Anorexia—Capecitabine—prostate cancer	8.69e-05	0.000586	CcSEcCtD
Desloratadine—Nausea—Estradiol—prostate cancer	8.69e-05	0.000585	CcSEcCtD
Desloratadine—Vomiting—Mitoxantrone—prostate cancer	8.66e-05	0.000584	CcSEcCtD
Desloratadine—Convulsion—Prednisone—prostate cancer	8.62e-05	0.000581	CcSEcCtD
Desloratadine—Rash—Mitoxantrone—prostate cancer	8.59e-05	0.000579	CcSEcCtD
Desloratadine—Dermatitis—Mitoxantrone—prostate cancer	8.58e-05	0.000578	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Docetaxel—prostate cancer	8.58e-05	0.000578	CcSEcCtD
Desloratadine—Headache—Mitoxantrone—prostate cancer	8.54e-05	0.000575	CcSEcCtD
Desloratadine—Insomnia—Docetaxel—prostate cancer	8.52e-05	0.000574	CcSEcCtD
Desloratadine—Myalgia—Prednisone—prostate cancer	8.47e-05	0.000571	CcSEcCtD
Desloratadine—Dyspnoea—Docetaxel—prostate cancer	8.4e-05	0.000566	CcSEcCtD
Desloratadine—Somnolence—Docetaxel—prostate cancer	8.37e-05	0.000564	CcSEcCtD
Desloratadine—Hypersensitivity—Etoposide—prostate cancer	8.35e-05	0.000562	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Capecitabine—prostate cancer	8.31e-05	0.00056	CcSEcCtD
Desloratadine—Cardiac disorder—Epirubicin—prostate cancer	8.3e-05	0.000559	CcSEcCtD
Desloratadine—Dyspepsia—Docetaxel—prostate cancer	8.29e-05	0.000558	CcSEcCtD
Desloratadine—Hepatitis—Doxorubicin—prostate cancer	8.27e-05	0.000557	CcSEcCtD
Desloratadine—Insomnia—Capecitabine—prostate cancer	8.25e-05	0.000556	CcSEcCtD
Desloratadine—Pharyngitis—Doxorubicin—prostate cancer	8.21e-05	0.000553	CcSEcCtD
Desloratadine—Decreased appetite—Docetaxel—prostate cancer	8.19e-05	0.000552	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Docetaxel—prostate cancer	8.13e-05	0.000548	CcSEcCtD
Desloratadine—Asthenia—Etoposide—prostate cancer	8.13e-05	0.000548	CcSEcCtD
Desloratadine—Connective tissue disorder—Doxorubicin—prostate cancer	8.13e-05	0.000548	CcSEcCtD
Desloratadine—Dyspnoea—Capecitabine—prostate cancer	8.13e-05	0.000548	CcSEcCtD
Desloratadine—Anaphylactic shock—Prednisone—prostate cancer	8.12e-05	0.000547	CcSEcCtD
Desloratadine—Oedema—Prednisone—prostate cancer	8.12e-05	0.000547	CcSEcCtD
Desloratadine—Fatigue—Docetaxel—prostate cancer	8.12e-05	0.000547	CcSEcCtD
Desloratadine—Nausea—Mitoxantrone—prostate cancer	8.09e-05	0.000545	CcSEcCtD
Desloratadine—Infection—Prednisone—prostate cancer	8.07e-05	0.000544	CcSEcCtD
Desloratadine—Dyspepsia—Capecitabine—prostate cancer	8.03e-05	0.000541	CcSEcCtD
Desloratadine—Pruritus—Etoposide—prostate cancer	8.02e-05	0.00054	CcSEcCtD
Desloratadine—Nervous system disorder—Prednisone—prostate cancer	7.97e-05	0.000537	CcSEcCtD
Desloratadine—Tachycardia—Prednisone—prostate cancer	7.93e-05	0.000534	CcSEcCtD
Desloratadine—Decreased appetite—Capecitabine—prostate cancer	7.93e-05	0.000534	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Capecitabine—prostate cancer	7.87e-05	0.00053	CcSEcCtD
Desloratadine—Fatigue—Capecitabine—prostate cancer	7.86e-05	0.00053	CcSEcCtD
Desloratadine—Mental disorder—Epirubicin—prostate cancer	7.83e-05	0.000528	CcSEcCtD
Desloratadine—Erythema—Epirubicin—prostate cancer	7.78e-05	0.000524	CcSEcCtD
Desloratadine—Diarrhoea—Etoposide—prostate cancer	7.75e-05	0.000522	CcSEcCtD
Desloratadine—Anorexia—Prednisone—prostate cancer	7.74e-05	0.000522	CcSEcCtD
Desloratadine—Gastrointestinal pain—Docetaxel—prostate cancer	7.7e-05	0.000519	CcSEcCtD
Desloratadine—Cardiac disorder—Doxorubicin—prostate cancer	7.68e-05	0.000517	CcSEcCtD
Desloratadine—Dizziness—Etoposide—prostate cancer	7.49e-05	0.000505	CcSEcCtD
Desloratadine—Gastrointestinal pain—Capecitabine—prostate cancer	7.46e-05	0.000502	CcSEcCtD
Desloratadine—Abdominal pain—Docetaxel—prostate cancer	7.45e-05	0.000502	CcSEcCtD
Desloratadine—Body temperature increased—Docetaxel—prostate cancer	7.45e-05	0.000502	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Prednisone—prostate cancer	7.4e-05	0.000498	CcSEcCtD
Desloratadine—Insomnia—Prednisone—prostate cancer	7.35e-05	0.000495	CcSEcCtD
Desloratadine—Mental disorder—Doxorubicin—prostate cancer	7.25e-05	0.000488	CcSEcCtD
Desloratadine—Urticaria—Capecitabine—prostate cancer	7.24e-05	0.000488	CcSEcCtD
Desloratadine—Body temperature increased—Capecitabine—prostate cancer	7.21e-05	0.000486	CcSEcCtD
Desloratadine—Abdominal pain—Capecitabine—prostate cancer	7.21e-05	0.000486	CcSEcCtD
Desloratadine—Vomiting—Etoposide—prostate cancer	7.21e-05	0.000485	CcSEcCtD
Desloratadine—Erythema—Doxorubicin—prostate cancer	7.2e-05	0.000485	CcSEcCtD
Desloratadine—Agitation—Epirubicin—prostate cancer	7.15e-05	0.000482	CcSEcCtD
Desloratadine—Dyspepsia—Prednisone—prostate cancer	7.15e-05	0.000482	CcSEcCtD
Desloratadine—Rash—Etoposide—prostate cancer	7.15e-05	0.000481	CcSEcCtD
Desloratadine—Dermatitis—Etoposide—prostate cancer	7.14e-05	0.000481	CcSEcCtD
Desloratadine—Headache—Etoposide—prostate cancer	7.1e-05	0.000478	CcSEcCtD
Desloratadine—Decreased appetite—Prednisone—prostate cancer	7.06e-05	0.000476	CcSEcCtD
Desloratadine—Fatigue—Prednisone—prostate cancer	7e-05	0.000472	CcSEcCtD
Desloratadine—Hypersensitivity—Docetaxel—prostate cancer	6.94e-05	0.000467	CcSEcCtD
Desloratadine—Palpitations—Epirubicin—prostate cancer	6.88e-05	0.000463	CcSEcCtD
Desloratadine—Cough—Epirubicin—prostate cancer	6.79e-05	0.000458	CcSEcCtD
Desloratadine—Asthenia—Docetaxel—prostate cancer	6.76e-05	0.000455	CcSEcCtD
Desloratadine—Convulsion—Epirubicin—prostate cancer	6.74e-05	0.000454	CcSEcCtD
Desloratadine—Nausea—Etoposide—prostate cancer	6.73e-05	0.000453	CcSEcCtD
Desloratadine—Hypersensitivity—Capecitabine—prostate cancer	6.72e-05	0.000453	CcSEcCtD
Desloratadine—Pruritus—Docetaxel—prostate cancer	6.66e-05	0.000449	CcSEcCtD
Desloratadine—Gastrointestinal pain—Prednisone—prostate cancer	6.64e-05	0.000447	CcSEcCtD
Desloratadine—Myalgia—Epirubicin—prostate cancer	6.63e-05	0.000446	CcSEcCtD
Desloratadine—Agitation—Doxorubicin—prostate cancer	6.62e-05	0.000446	CcSEcCtD
Desloratadine—Asthenia—Capecitabine—prostate cancer	6.54e-05	0.000441	CcSEcCtD
Desloratadine—Dry mouth—Epirubicin—prostate cancer	6.48e-05	0.000437	CcSEcCtD
Desloratadine—Urticaria—Prednisone—prostate cancer	6.45e-05	0.000435	CcSEcCtD
Desloratadine—Pruritus—Capecitabine—prostate cancer	6.45e-05	0.000435	CcSEcCtD
Desloratadine—Diarrhoea—Docetaxel—prostate cancer	6.44e-05	0.000434	CcSEcCtD
Desloratadine—Abdominal pain—Prednisone—prostate cancer	6.42e-05	0.000433	CcSEcCtD
Desloratadine—Body temperature increased—Prednisone—prostate cancer	6.42e-05	0.000433	CcSEcCtD
Desloratadine—Palpitations—Doxorubicin—prostate cancer	6.36e-05	0.000429	CcSEcCtD
Desloratadine—Oedema—Epirubicin—prostate cancer	6.35e-05	0.000428	CcSEcCtD
Desloratadine—Anaphylactic shock—Epirubicin—prostate cancer	6.35e-05	0.000428	CcSEcCtD
Desloratadine—Infection—Epirubicin—prostate cancer	6.31e-05	0.000425	CcSEcCtD
Desloratadine—Cough—Doxorubicin—prostate cancer	6.28e-05	0.000423	CcSEcCtD
Desloratadine—Convulsion—Doxorubicin—prostate cancer	6.24e-05	0.00042	CcSEcCtD
Desloratadine—Diarrhoea—Capecitabine—prostate cancer	6.24e-05	0.00042	CcSEcCtD
Desloratadine—Nervous system disorder—Epirubicin—prostate cancer	6.23e-05	0.00042	CcSEcCtD
Desloratadine—Dizziness—Docetaxel—prostate cancer	6.23e-05	0.00042	CcSEcCtD
Desloratadine—Tachycardia—Epirubicin—prostate cancer	6.2e-05	0.000418	CcSEcCtD
Desloratadine—Myalgia—Doxorubicin—prostate cancer	6.13e-05	0.000413	CcSEcCtD
Desloratadine—Anorexia—Epirubicin—prostate cancer	6.06e-05	0.000408	CcSEcCtD
Desloratadine—Dizziness—Capecitabine—prostate cancer	6.03e-05	0.000406	CcSEcCtD
Desloratadine—Dry mouth—Doxorubicin—prostate cancer	6e-05	0.000404	CcSEcCtD
Desloratadine—Vomiting—Docetaxel—prostate cancer	5.99e-05	0.000403	CcSEcCtD
Desloratadine—Hypersensitivity—Prednisone—prostate cancer	5.98e-05	0.000403	CcSEcCtD
Desloratadine—Rash—Docetaxel—prostate cancer	5.94e-05	0.0004	CcSEcCtD
Desloratadine—Dermatitis—Docetaxel—prostate cancer	5.93e-05	0.0004	CcSEcCtD
Desloratadine—Headache—Docetaxel—prostate cancer	5.9e-05	0.000397	CcSEcCtD
Desloratadine—Anaphylactic shock—Doxorubicin—prostate cancer	5.88e-05	0.000396	CcSEcCtD
Desloratadine—Oedema—Doxorubicin—prostate cancer	5.88e-05	0.000396	CcSEcCtD
Desloratadine—Infection—Doxorubicin—prostate cancer	5.84e-05	0.000393	CcSEcCtD
Desloratadine—Asthenia—Prednisone—prostate cancer	5.83e-05	0.000393	CcSEcCtD
Desloratadine—Vomiting—Capecitabine—prostate cancer	5.8e-05	0.000391	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.79e-05	0.00039	CcSEcCtD
Desloratadine—Nervous system disorder—Doxorubicin—prostate cancer	5.76e-05	0.000388	CcSEcCtD
Desloratadine—Rash—Capecitabine—prostate cancer	5.75e-05	0.000387	CcSEcCtD
Desloratadine—Pruritus—Prednisone—prostate cancer	5.75e-05	0.000387	CcSEcCtD
Desloratadine—Insomnia—Epirubicin—prostate cancer	5.75e-05	0.000387	CcSEcCtD
Desloratadine—Dermatitis—Capecitabine—prostate cancer	5.74e-05	0.000387	CcSEcCtD
Desloratadine—Tachycardia—Doxorubicin—prostate cancer	5.74e-05	0.000386	CcSEcCtD
Desloratadine—Headache—Capecitabine—prostate cancer	5.71e-05	0.000385	CcSEcCtD
Desloratadine—Dyspnoea—Epirubicin—prostate cancer	5.66e-05	0.000382	CcSEcCtD
Desloratadine—Somnolence—Epirubicin—prostate cancer	5.65e-05	0.00038	CcSEcCtD
Desloratadine—Anorexia—Doxorubicin—prostate cancer	5.6e-05	0.000377	CcSEcCtD
Desloratadine—Nausea—Docetaxel—prostate cancer	5.59e-05	0.000377	CcSEcCtD
Desloratadine—Dyspepsia—Epirubicin—prostate cancer	5.59e-05	0.000377	CcSEcCtD
Desloratadine—Diarrhoea—Prednisone—prostate cancer	5.56e-05	0.000374	CcSEcCtD
Desloratadine—Decreased appetite—Epirubicin—prostate cancer	5.52e-05	0.000372	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Epirubicin—prostate cancer	5.48e-05	0.000369	CcSEcCtD
Desloratadine—Fatigue—Epirubicin—prostate cancer	5.48e-05	0.000369	CcSEcCtD
Desloratadine—Nausea—Capecitabine—prostate cancer	5.42e-05	0.000365	CcSEcCtD
Desloratadine—Dizziness—Prednisone—prostate cancer	5.37e-05	0.000362	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.36e-05	0.000361	CcSEcCtD
Desloratadine—Insomnia—Doxorubicin—prostate cancer	5.32e-05	0.000358	CcSEcCtD
Desloratadine—Dyspnoea—Doxorubicin—prostate cancer	5.24e-05	0.000353	CcSEcCtD
Desloratadine—Somnolence—Doxorubicin—prostate cancer	5.23e-05	0.000352	CcSEcCtD
Desloratadine—Gastrointestinal pain—Epirubicin—prostate cancer	5.19e-05	0.00035	CcSEcCtD
Desloratadine—Dyspepsia—Doxorubicin—prostate cancer	5.17e-05	0.000349	CcSEcCtD
Desloratadine—Vomiting—Prednisone—prostate cancer	5.16e-05	0.000348	CcSEcCtD
Desloratadine—Rash—Prednisone—prostate cancer	5.12e-05	0.000345	CcSEcCtD
Desloratadine—Dermatitis—Prednisone—prostate cancer	5.12e-05	0.000345	CcSEcCtD
Desloratadine—Decreased appetite—Doxorubicin—prostate cancer	5.11e-05	0.000344	CcSEcCtD
Desloratadine—Headache—Prednisone—prostate cancer	5.09e-05	0.000343	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.07e-05	0.000342	CcSEcCtD
Desloratadine—Fatigue—Doxorubicin—prostate cancer	5.07e-05	0.000341	CcSEcCtD
Desloratadine—Urticaria—Epirubicin—prostate cancer	5.05e-05	0.00034	CcSEcCtD
Desloratadine—Body temperature increased—Epirubicin—prostate cancer	5.02e-05	0.000338	CcSEcCtD
Desloratadine—Abdominal pain—Epirubicin—prostate cancer	5.02e-05	0.000338	CcSEcCtD
Desloratadine—Nausea—Prednisone—prostate cancer	4.82e-05	0.000325	CcSEcCtD
Desloratadine—Gastrointestinal pain—Doxorubicin—prostate cancer	4.81e-05	0.000324	CcSEcCtD
Desloratadine—Hypersensitivity—Epirubicin—prostate cancer	4.68e-05	0.000315	CcSEcCtD
Desloratadine—Urticaria—Doxorubicin—prostate cancer	4.67e-05	0.000315	CcSEcCtD
Desloratadine—Abdominal pain—Doxorubicin—prostate cancer	4.65e-05	0.000313	CcSEcCtD
Desloratadine—Body temperature increased—Doxorubicin—prostate cancer	4.65e-05	0.000313	CcSEcCtD
Desloratadine—Asthenia—Epirubicin—prostate cancer	4.56e-05	0.000307	CcSEcCtD
Desloratadine—Pruritus—Epirubicin—prostate cancer	4.49e-05	0.000303	CcSEcCtD
Desloratadine—Diarrhoea—Epirubicin—prostate cancer	4.35e-05	0.000293	CcSEcCtD
Desloratadine—Hypersensitivity—Doxorubicin—prostate cancer	4.33e-05	0.000292	CcSEcCtD
Desloratadine—Asthenia—Doxorubicin—prostate cancer	4.22e-05	0.000284	CcSEcCtD
Desloratadine—Dizziness—Epirubicin—prostate cancer	4.2e-05	0.000283	CcSEcCtD
Desloratadine—Pruritus—Doxorubicin—prostate cancer	4.16e-05	0.00028	CcSEcCtD
Desloratadine—Vomiting—Epirubicin—prostate cancer	4.04e-05	0.000272	CcSEcCtD
Desloratadine—Diarrhoea—Doxorubicin—prostate cancer	4.02e-05	0.000271	CcSEcCtD
Desloratadine—Rash—Epirubicin—prostate cancer	4.01e-05	0.00027	CcSEcCtD
Desloratadine—Dermatitis—Epirubicin—prostate cancer	4e-05	0.00027	CcSEcCtD
Desloratadine—Headache—Epirubicin—prostate cancer	3.98e-05	0.000268	CcSEcCtD
Desloratadine—Dizziness—Doxorubicin—prostate cancer	3.89e-05	0.000262	CcSEcCtD
Desloratadine—Nausea—Epirubicin—prostate cancer	3.77e-05	0.000254	CcSEcCtD
Desloratadine—Vomiting—Doxorubicin—prostate cancer	3.74e-05	0.000252	CcSEcCtD
Desloratadine—Rash—Doxorubicin—prostate cancer	3.71e-05	0.00025	CcSEcCtD
Desloratadine—Dermatitis—Doxorubicin—prostate cancer	3.7e-05	0.000249	CcSEcCtD
Desloratadine—Headache—Doxorubicin—prostate cancer	3.68e-05	0.000248	CcSEcCtD
Desloratadine—Nausea—Doxorubicin—prostate cancer	3.49e-05	0.000235	CcSEcCtD
Desloratadine—HRH1—GPCR downstream signaling—CXCL8—prostate cancer	5.4e-06	5.77e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—SLC5A5—prostate cancer	5.4e-06	5.76e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—JAK2—prostate cancer	5.37e-06	5.74e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NQO1—prostate cancer	5.34e-06	5.7e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NCOA2—prostate cancer	5.33e-06	5.69e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.32e-06	5.68e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NCOA2—prostate cancer	5.28e-06	5.64e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP2E1—prostate cancer	5.27e-06	5.63e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—TH—prostate cancer	5.26e-06	5.62e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.23e-06	5.58e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NQO1—prostate cancer	5.21e-06	5.57e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP3A4—prostate cancer	5.21e-06	5.56e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—LPL—prostate cancer	5.2e-06	5.55e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.18e-06	5.53e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—HPGDS—prostate cancer	5.16e-06	5.51e-05	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—IL2—prostate cancer	5.16e-06	5.51e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PDGFRB—prostate cancer	5.15e-06	5.5e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—TH—prostate cancer	5.14e-06	5.49e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP2C19—prostate cancer	5.13e-06	5.48e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP1B1—prostate cancer	5.12e-06	5.47e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CB—prostate cancer	5.1e-06	5.45e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—SLC5A5—prostate cancer	5.09e-06	5.43e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP3A4—prostate cancer	5.08e-06	5.43e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—SLC5A5—prostate cancer	5.04e-06	5.38e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ITGB3—prostate cancer	5.02e-06	5.36e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ACHE—prostate cancer	5.01e-06	5.35e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTT1—prostate cancer	5.01e-06	5.35e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP1B1—prostate cancer	5e-06	5.34e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP2E1—prostate cancer	4.97e-06	5.3e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GGT1—prostate cancer	4.96e-06	5.29e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP2A6—prostate cancer	4.95e-06	5.28e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.93e-06	5.26e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP2E1—prostate cancer	4.92e-06	5.26e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NQO1—prostate cancer	4.91e-06	5.24e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CXCL8—prostate cancer	4.9e-06	5.24e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NCOA1—prostate cancer	4.88e-06	5.22e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ERBB3—prostate cancer	4.87e-06	5.2e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NQO1—prostate cancer	4.87e-06	5.2e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FGFR2—prostate cancer	4.86e-06	5.19e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—TH—prostate cancer	4.84e-06	5.17e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GGT1—prostate cancer	4.84e-06	5.17e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—AKR1C3—prostate cancer	4.81e-06	5.14e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP19A1—prostate cancer	4.81e-06	5.14e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—TH—prostate cancer	4.8e-06	5.12e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP3A4—prostate cancer	4.79e-06	5.11e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PRKACB—prostate cancer	4.79e-06	5.11e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.77e-06	5.09e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NCOA1—prostate cancer	4.77e-06	5.09e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP3A4—prostate cancer	4.75e-06	5.07e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP17A1—prostate cancer	4.74e-06	5.06e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.72e-06	5.04e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP1B1—prostate cancer	4.71e-06	5.03e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP19A1—prostate cancer	4.7e-06	5.02e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL2—prostate cancer	4.69e-06	5e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.67e-06	4.99e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TERT—prostate cancer	4.67e-06	4.99e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP1B1—prostate cancer	4.67e-06	4.98e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—RXRA—prostate cancer	4.65e-06	4.96e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GGT1—prostate cancer	4.56e-06	4.87e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—RXRA—prostate cancer	4.53e-06	4.84e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GGT1—prostate cancer	4.52e-06	4.83e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.52e-06	4.83e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NCOA2—prostate cancer	4.52e-06	4.82e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NCOA1—prostate cancer	4.49e-06	4.8e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—COMT—prostate cancer	4.48e-06	4.78e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HIF1A—prostate cancer	4.47e-06	4.77e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTP1—prostate cancer	4.45e-06	4.76e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NCOA1—prostate cancer	4.45e-06	4.76e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP19A1—prostate cancer	4.43e-06	4.73e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP19A1—prostate cancer	4.39e-06	4.69e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ITPR1—prostate cancer	4.38e-06	4.68e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—COMT—prostate cancer	4.37e-06	4.66e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—LEP—prostate cancer	4.36e-06	4.65e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTP1—prostate cancer	4.35e-06	4.64e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CAV1—prostate cancer	4.32e-06	4.61e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.31e-06	4.6e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SLC5A5—prostate cancer	4.31e-06	4.6e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ITPR1—prostate cancer	4.28e-06	4.57e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—RXRA—prostate cancer	4.27e-06	4.56e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KDR—prostate cancer	4.27e-06	4.56e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—RXRA—prostate cancer	4.24e-06	4.52e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP2E1—prostate cancer	4.21e-06	4.49e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ESR1—prostate cancer	4.16e-06	4.44e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NQO1—prostate cancer	4.16e-06	4.44e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—TYMS—prostate cancer	4.14e-06	4.42e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.12e-06	4.4e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—COMT—prostate cancer	4.12e-06	4.4e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—TH—prostate cancer	4.1e-06	4.38e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTP1—prostate cancer	4.1e-06	4.37e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTM1—prostate cancer	4.09e-06	4.37e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—COMT—prostate cancer	4.08e-06	4.36e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.07e-06	4.35e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—BAD—prostate cancer	4.06e-06	4.34e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTP1—prostate cancer	4.06e-06	4.34e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP3A4—prostate cancer	4.06e-06	4.33e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—TYMS—prostate cancer	4.04e-06	4.32e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.04e-06	4.31e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ITPR1—prostate cancer	4.03e-06	4.3e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—LPL—prostate cancer	4.02e-06	4.29e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ITPR1—prostate cancer	4e-06	4.27e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTM1—prostate cancer	3.99e-06	4.27e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP1B1—prostate cancer	3.99e-06	4.26e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CG—prostate cancer	3.93e-06	4.2e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—APC—prostate cancer	3.93e-06	4.2e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.93e-06	4.2e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—LPL—prostate cancer	3.92e-06	4.19e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IRS1—prostate cancer	3.89e-06	4.15e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EGF—prostate cancer	3.89e-06	4.15e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP1A1—prostate cancer	3.88e-06	4.14e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GGT1—prostate cancer	3.86e-06	4.13e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ERCC2—prostate cancer	3.85e-06	4.11e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—TYMS—prostate cancer	3.81e-06	4.07e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NCOA1—prostate cancer	3.81e-06	4.06e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP1A1—prostate cancer	3.79e-06	4.04e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—TYMS—prostate cancer	3.78e-06	4.03e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GSK3B—prostate cancer	3.78e-06	4.03e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTM1—prostate cancer	3.76e-06	4.02e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ERCC2—prostate cancer	3.76e-06	4.01e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP19A1—prostate cancer	3.75e-06	4.01e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTM1—prostate cancer	3.73e-06	3.99e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—INS—prostate cancer	3.72e-06	3.98e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—LPL—prostate cancer	3.7e-06	3.95e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—LPL—prostate cancer	3.66e-06	3.91e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CREBBP—prostate cancer	3.65e-06	3.9e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—RXRA—prostate cancer	3.62e-06	3.87e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—MTHFR—prostate cancer	3.62e-06	3.86e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IGF1—prostate cancer	3.6e-06	3.85e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—EGFR—prostate cancer	3.58e-06	3.83e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.57e-06	3.81e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PPARA—prostate cancer	3.55e-06	3.79e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ERCC2—prostate cancer	3.54e-06	3.78e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP1A1—prostate cancer	3.54e-06	3.78e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—MTHFR—prostate cancer	3.53e-06	3.77e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.52e-06	3.76e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ERCC2—prostate cancer	3.51e-06	3.75e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—COMT—prostate cancer	3.49e-06	3.72e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAP2K1—prostate cancer	3.48e-06	3.72e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTP1—prostate cancer	3.47e-06	3.71e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PPARA—prostate cancer	3.46e-06	3.7e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CD—prostate cancer	3.46e-06	3.69e-05	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CA—prostate cancer	3.43e-06	3.66e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SERPINE1—prostate cancer	3.42e-06	3.65e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ITPR1—prostate cancer	3.41e-06	3.65e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—KRAS—prostate cancer	3.39e-06	3.62e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.36e-06	3.59e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CAV1—prostate cancer	3.34e-06	3.56e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—MTHFR—prostate cancer	3.33e-06	3.55e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FGF2—prostate cancer	3.31e-06	3.54e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—MTHFR—prostate cancer	3.3e-06	3.52e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NOS3—prostate cancer	3.27e-06	3.49e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PPARA—prostate cancer	3.26e-06	3.49e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CAV1—prostate cancer	3.26e-06	3.48e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PPARA—prostate cancer	3.24e-06	3.46e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—TYMS—prostate cancer	3.23e-06	3.45e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTM1—prostate cancer	3.19e-06	3.41e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.19e-06	3.4e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—JAK2—prostate cancer	3.17e-06	3.39e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—LPL—prostate cancer	3.13e-06	3.34e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	3.11e-06	3.32e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MDM2—prostate cancer	3.1e-06	3.31e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CAV1—prostate cancer	3.07e-06	3.28e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ERBB2—prostate cancer	3.05e-06	3.26e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CAV1—prostate cancer	3.04e-06	3.25e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CG—prostate cancer	3.04e-06	3.25e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP1A1—prostate cancer	3.02e-06	3.23e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CB—prostate cancer	3.01e-06	3.22e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ERCC2—prostate cancer	3e-06	3.2e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CG—prostate cancer	2.97e-06	3.17e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.91e-06	3.1e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CXCL8—prostate cancer	2.9e-06	3.09e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—INS—prostate cancer	2.88e-06	3.07e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN1B—prostate cancer	2.83e-06	3.02e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—MTHFR—prostate cancer	2.82e-06	3.01e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CREBBP—prostate cancer	2.82e-06	3.01e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—INS—prostate cancer	2.81e-06	3e-05	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—AKT1—prostate cancer	2.8e-06	2.99e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.8e-06	2.98e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CASP3—prostate cancer	2.77e-06	2.96e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.77e-06	2.96e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL2—prostate cancer	2.77e-06	2.96e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PPARA—prostate cancer	2.77e-06	2.95e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL6—prostate cancer	2.75e-06	2.94e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CREBBP—prostate cancer	2.75e-06	2.94e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCND1—prostate cancer	2.7e-06	2.88e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	2.67e-06	2.85e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.67e-06	2.85e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—INS—prostate cancer	2.65e-06	2.83e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—INS—prostate cancer	2.62e-06	2.8e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MMP9—prostate cancer	2.62e-06	2.8e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	2.61e-06	2.79e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CD—prostate cancer	2.61e-06	2.78e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PTEN—prostate cancer	2.6e-06	2.78e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CAV1—prostate cancer	2.6e-06	2.78e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CREBBP—prostate cancer	2.59e-06	2.77e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CREBBP—prostate cancer	2.57e-06	2.74e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—AKT1—prostate cancer	2.54e-06	2.71e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NOS3—prostate cancer	2.52e-06	2.69e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EP300—prostate cancer	2.48e-06	2.65e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.48e-06	2.65e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NOS3—prostate cancer	2.46e-06	2.63e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.46e-06	2.62e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CD—prostate cancer	2.44e-06	2.6e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SRC—prostate cancer	2.42e-06	2.58e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.37e-06	2.53e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—VEGFA—prostate cancer	2.35e-06	2.51e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STAT3—prostate cancer	2.33e-06	2.49e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CB—prostate cancer	2.33e-06	2.49e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NOS3—prostate cancer	2.32e-06	2.48e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTGS2—prostate cancer	2.31e-06	2.46e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NOS3—prostate cancer	2.3e-06	2.46e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CB—prostate cancer	2.27e-06	2.43e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTGS2—prostate cancer	2.25e-06	2.4e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—INS—prostate cancer	2.24e-06	2.39e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CREBBP—prostate cancer	2.2e-06	2.34e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MYC—prostate cancer	2.16e-06	2.31e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TGFB1—prostate cancer	2.16e-06	2.31e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.14e-06	2.29e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CB—prostate cancer	2.12e-06	2.27e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTGS2—prostate cancer	2.12e-06	2.27e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EGFR—prostate cancer	2.12e-06	2.26e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTGS2—prostate cancer	2.1e-06	2.25e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CD—prostate cancer	2.08e-06	2.22e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTEN—prostate cancer	2.01e-06	2.15e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KRAS—prostate cancer	2e-06	2.14e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NOS3—prostate cancer	1.97e-06	2.1e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTEN—prostate cancer	1.96e-06	2.1e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—EP300—prostate cancer	1.92e-06	2.05e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—EP300—prostate cancer	1.87e-06	2e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTEN—prostate cancer	1.85e-06	1.98e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	1.84e-06	1.96e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTEN—prostate cancer	1.83e-06	1.96e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.81e-06	1.94e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTGS2—prostate cancer	1.8e-06	1.92e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TP53—prostate cancer	1.78e-06	1.9e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—EP300—prostate cancer	1.77e-06	1.88e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—EP300—prostate cancer	1.75e-06	1.87e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL6—prostate cancer	1.63e-06	1.74e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTEN—prostate cancer	1.57e-06	1.67e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—AKT1—prostate cancer	1.5e-06	1.6e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—EP300—prostate cancer	1.5e-06	1.6e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.42e-06	1.52e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CA—prostate cancer	1.39e-06	1.48e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.31e-06	1.39e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.29e-06	1.38e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—AKT1—prostate cancer	1.16e-06	1.24e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—AKT1—prostate cancer	1.13e-06	1.21e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.11e-06	1.18e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—AKT1—prostate cancer	1.07e-06	1.14e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—AKT1—prostate cancer	1.06e-06	1.13e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—AKT1—prostate cancer	9.04e-07	9.65e-06	CbGpPWpGaD
